Our study will test the hypothesis that frequent, high-coverage MISR use will reduce harms to clients, across a range of outcome measures including fatal and non-fatal overdose, blood borne viral infections and injecting-related injuries and their sequalae.
2023-2026
Using best-practice methods in the field, we will establish a cohort of 3000 people who use the Medically Supervised Injecting Rooms that will be followed through record linkage along with a nested sub-cohort of 1200 service users who will be followed up annually using existing infrastructure from the Burnet Institute's SuperMIX cohort study, the largest and only active prospective cohort study of people who inject drugs in Australia.
Our study will provide the evidence needed to inform debate about the MSIRs and our design will deliver the strongest evidence in a strong partnership approach within a timeframe that will inform ongoing policy and practice around supervised injecting facilities over the coming decade.
Funding
Partners
- NHMRC
- Victorian Government Department of Health
- North Richmond Comnunity Health
- Cohealth
Partners +
Collaborators
- Victorian Government Department of Health
- North Richmond Comnunity Health
- Cohealth
- University of Bristol
- Kirby Institute
- British Columbia Centre on Substance Use
- St Vincent’s Hospital
Project
Team
Meet the project team. Together, we are translating research into better health, for all.
